Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Surgical Endoscopy|September 23, 2017
Understanding intestinal glucose transporter expression in obese compared to non-obese subjectsRebecca A Deal, Yueming Tang, Reid Fletcher, et al.Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 6, 2011
Necdin-E2F4 interaction provides insulin-sensitizing effect after weight loss induced by gastric bypass surgeryZehra N Pamuklar, Jiegen Chen, Michael Muehlbauer, et al.Obesity Surgery|July 15, 2006
Weight, dietary and physical activity behaviors two years after gastric bypassHeidi J Silver, Alfonso Torquati, Gordon L Jensen, et al.The American Surgeon|August 1, 2006
Internal hernia: postoperative complication of roux-en-Y gastric bypass surgeryAaron Eckhauser, Alfonso Torquati, Yassar Youssef, et al.Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|July 16, 2020
The Impact of Perioperative Antibiotic Prophylaxis on Weight Loss Following Laparoscopic Sleeve GastrectomyRichard Jacobson, Samantha Terranella, Connor Booker, et al.Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|January 6, 2005
Preoperative risk factors for common bile duct stones: defining the patient at high risk in the laparoscopic cholecystectomy eraMichele Grande, Alfonso Torquati, Gianfranco Tucci, et al.Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 3, 2016
Predictors of long-term success after laparoscopic Roux-en-Y gastric bypass in African-American womenPhilip A Omotosho, Joel A Rodriguez, Kunoor Jain-Spangler, et al.Obesity Surgery|September 1, 2019
Effects of Roux-en-Y Gastric Bypass on Osteoclast Activity and Bone Density in Morbidly Obese Patients with Type 2 DiabetesLaurel L Tangalakis, Lawrence Tabone, Anna Spagnoli, et al.Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 2, 2010
Pre-Lap-Band group education in Medicaid population: does it really make a difference?Joseph A Talarico, Alfonso Torquati, Erin M McCarthy, et al.Surgery|August 10, 2004
RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cellsAlfonso Torquati, Lynda O'rear, Lara Longobardi, et al.Pageof 7